Cuorips Inc.
|
| Code |
Sector |
Market |
Lead Underwriter |
Date of listing approval |
IPO Date |
| 4894 |
Pharmaceuticals |
Growth |
Nomura |
2023/05/23 |
2023/06/27 |
| 【Description】 |
| |
IPO Information |
| Opening Price |
Y1,680 |
Total Amount |
Y3,946,800,000 |
| IPO Price |
Y1,560 |
--Company |
Y2,439,840,000 |
Aggregate Value
(based on Initial Price) |
12,697
(Unit:1 million) |
--Leading Shareholder |
Y1,191,216,000 |
| Listed Shares(total) |
2,530,000 |
--Lead Manager |
Y315,744,000 |
| Trading Unit |
100 |
|
Offering Price PER
(based on previous period) |
-23.42 |
Offering Price PBR
(based on previous period) |
2.27 |
| 公開価格PER(今期予想ベース) |
-8.94 |
| Initial Price PER |
-25.23 |
Initial Price PBR |
2.45 |
| New Shares |
1,700,000 |
Existing Shares |
830,000（incl. O.A.） |
| Shares Outstanding |
Pre IPO |
5,857,916.00 |
PostIPO |
7,557,916.00 |
| Paid Up Capital |
PreIPO |
Y104,150,000 |
PostIPO |
Y909,656,000 |
| Use of Funds Raised |
|
Financial Data |
| Units:Y1,000 |
| Fiscal Year End |
|
Revenue |
Current Profit |
Net Profit |
Net Assets |
| 2020/03 |
Consolidated |
- |
- |
- |
- |
| Non-consolidated |
|
-176,987 |
-179,833 |
750,177 |
| 2021/03 |
Consolidated |
- |
- |
- |
- |
| Non-consolidated |
220 |
-295,845 |
-307,834 |
4,222,342 |
| 2022/03 |
Consolidated |
- |
- |
- |
- |
| Non-consolidated |
13,913 |
-373,140 |
-375,337 |
3,895,546 |
Recent Quarter
2022/12 |
Consolidated |
- |
- |
- |
- |
| Non-consolidated |
13,488 |
-356,243 |
-357,352 |
3,548,348 |
Results Forecast
2024/03 |
Consolidated |
- |
- |
- |
- |
| Non-consolidated |
215,000 |
-1,246,000 |
-1,249,000 |
- |
| Per Share |
Units:Y1 |
| Fiscal Year End |
|
Dividend |
Net Earning |
Equity |
|
| 2020/03 |
Consolidated |
0.00 |
- |
- |
|
| Non-consolidated |
-97.31 |
407.24 |
|
| 2021/03 |
Consolidated |
0.00 |
- |
- |
|
| Non-consolidated |
-123.65 |
751.03 |
|
| 2022/03 |
Consolidated |
0.00 |
- |
- |
|
| Non-consolidated |
-66.60 |
686.19 |
|
| Fiscal Year End |
|
Dividend |
Net Earning |
Equity |
|
Recent Quarter
2022/12 |
Consolidated |
|
- |
- |
|
| Non-consolidated |
-63.16 |
- |
|
Results Forecast
2024/03
| Consolidated
| 0.00 |
- |
- |
|
| Non-consolidated |
-174.50 |
- |
|
Comment |
| ■Over allotment(330,000) |
| Consolidated Subsidiaries |
| Name |
Address |
| Underwriters |
| Allocation |
Underwriter |
Tel |
| 92% |
Nomura |
03-3211-1811 |
| 7.5% |
SBI SECURITIES Co.,Ltd. |
03-5562-7210 |
| 0.5% |
Matsui |
03-5216-0606 |
| Data |
| Date of incorporation |
2017/03/21 |
| Company address |
Tokyo 103-0023 |
| Telephone |
03-6231-0043 |
| President |
|
| Homepage |
https://cuorips.co.jp/ |
| Auditor |
Azsa |
|
|
| Major Shareholders |
| Shareholder Name |
Ratio |
| |
15.75% |
| |
9.13% |
| |
8.35% |
| |
7.87% |
| |
7.87% |
| |
7.87% |
| |
7.22% |
| |
6.30% |
| |
4.30% |
| |
3.40% |
| Number of Employees |
46 as of 2023/04/30 |
| Birth Date of Representative |
1958/12/17 |
|
|
IPO最新情報、セミナー・イベント情報などをタイムリーにお届けします。
|
|
IPO関連ニュースをX（旧Twitter）でも掲載中。初値予想アンケートも実施中です！
|
|
今後の躍進が期待される注目銘柄のアナリストレポートをご覧いただけます。
|
|
個人投資家向けIRセミナーを開催しませんか？開催希望企業募集中！
|
|
